Denied hiting her head, chest pain, shortness of breath, lightheadeness, palpitations or any other symptoms associated with it.
In the ED, Vs 98.3 Hr 81, Bp 104/59, RR 20 Sats 90% RA.
syncope and low o2 sats, CTA was performed to r/u PE which was negative.
Past Medical History: Oncologic: * Ovarian cancer: - diagnosed of stage IIIC primary peritoneal papillary serous carcinoma in [**2174**] - optimal debulking surgery on [**2175-2-9**] - underwent six cycles of DoCaGem chemotherapy, which completed  in [**2175-7-22**].
- in [**2180-3-20**], her CA125 was measured at 42 and subsequent CT scanning on [**4-29**] showed an anterior chest wall mass, 4 cm x 4  cm, just to the left of the sternum.
She had a repeat MRI of the brain performed which showed progressive disease and commenced irinotecan and bevacizumab on [**2182-2-28**]; bevacizumab on [**2182-3-14**], most irinotecan on [**2182-2-28**].
- had grade 2 diarrhea after one dose of irinotecan as well as an ANC of [**Telephone/Fax (1) 111183**] cGy given tothe C-spine --> completed on [**2182-4-5**].
Family History: non-contributory  Physical Exam: Vitals: T: 97.2 P: 77 R: 18 BP: 132/70 SaO293% 3L: General: Awake, alert, NAD, speaking full sentences.cachectic HEENT: oropharinx clear, Neck: supple, no JVD Pulmonary: Crackles on the left side anteriorly.
Strength 4+ proximal LE, 4+ proximal upper extremity extension.
no babinsky   Pertinent Results: [**2182-4-11**] 06:43PM   WBC-5.7 RBC-3.62* HGB-11.0* HCT-31.9* MCV-88 MCH-30.5 MCHC-34.6 RDW-16.1* [**2182-4-11**] 06:43PM   NEUTS-91.1* BANDS-0 LYMPHS-7.6* MONOS-0.6* EOS-0.4 BASOS-0.3 [**2182-4-11**] 06:43PM   PLT SMR-LOW PLT COUNT-126* [**2182-4-11**] 06:43PM   PT-12.9 PTT-25.5 INR(PT)-1.1 [**2182-4-11**] 06:43PM   GLUCOSE-107* UREA N-19 CREAT-0.6 SODIUM-134 POTASSIUM-7.3* CHLORIDE-99 TOTAL CO2-27 ANION GAP-15 [**2182-4-11**] 06:43PM   CALCIUM-8.4 PHOSPHATE-4.8*# MAGNESIUM-2.1  Brief Hospital Course: 77-year-old woman with primary papillary serous carcinoma with brain and cervical spine metastases, status post XRT and recent irinotecan/bevacizumab presented after fall at home.
Chest CTA was negative for pulmonary embolism but was notable for bilateral airspace opacities.
She underwent a bronchoscopy with bronchoalveolar lavage positive for Pneumocystis jirovecii.
ABG was 7.54/26/66.
CXR revealed worsened bilateral infiltrates.
